Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Final Analysis of Day +100 Survival By Prior Hematopoietic Stem Cell Transplant Type from an Expanded Access Study of Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome

Paul G Richardson, MD, Angela R. Smith, MD MS, Brandon Triplett, MD, Nancy Kernan, MD, Leslie Lehmann, MD, Robert J. Ryan, Robin L. Hume, MS, William Martin Tappe, MD, Stephan A Grupp, MD PhD

Blood (2017) 130 (Supplement 1): 3224.

https://doi.org/10.1182/blood.V130.Suppl_1.3224.3224

Published: 2017

Journal Articles

Adults Receiving Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program

Paul G Richardson, MD, Joseph H. Antin, MD, Sergio A. Giralt, MD, Robert J. Ryan, Wei Liang, Robin L. Hume, MS, William Martin Tappe, MD, Nancy A. Kernan, MD

Blood (2017) 130 (Supplement 1): 3225.

https://doi.org/10.1182/blood.V130.Suppl_1.3225.3225

Published: 2017

Journal Articles

Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Neuroblastoma: Final Data from the Defibrotide Expanded-Access Program

Stephan A Grupp, MD PhD, Brandon Triplett, MD, Araz Marachelian, MD, Sonata Jodele, MD, Robert J. Ryan, Robin L. Hume, MS, William Martin Tappe, MD, Paul G Richardson, MD

Blood (2017) 130 (Supplement 1): 4549.

https://doi.org/10.1182/blood.V130.Suppl_1.4549.4549

Published: 2017

Journal Articles

Pooled Analysis of Day +100 Survival for Defibrotide-Treated Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) and Ventilator or Dialysis Dependence Following Hematopoietic Stem Cell Transplantation (HSCT)

Paul G Richardson, MD, Angela R. Smith, MD MS, Nancy A. Kernan, MD, Joseph H. Antin, MD, Leslie Lehmann, MD, Robert J. Ryan, Robin L. Hume, MS, William Martin Tappe, MD, Stephan A Grupp, MD PhD

Blood (2017) 130 (Supplement 1): 1946.

https://doi.org/10.1182/blood.V130.Suppl_1.1946.1946

Published: 2017

Journal Articles

Efficacy and Safety of Defibrotide in Pediatric Patients with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program

Nancy A. Kernan, MD, Angela R. Smith, MD MS, Brandon Triplett, MD, Leslie Lehmann, MD, Robert J. Ryan, Wei Liang, Robin L. Hume, MS, William Martin Tappe, MD, Stephan A Grupp, MD PhD

Blood (2017) 130 (Supplement 1): 1948.

https://doi.org/10.1182/blood.V130.Suppl_1.1948.1948

Published: 2017

Journal Articles

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Blood (2016) 127 (13): 1656–1665.

https://doi.org/10.1182/blood-2015-10-676924

Published: 2016

Includes: Supplemental data

Journal Articles

Early Initiation of Defibrotide in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation Improves Day +100 Survival

Paul G. Richardson, MD, Angela R. Smith, MD MS, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Joseph H. Antin, MD, Leslie E. Lehmann, MD, Maja Miloslavsky, PhD, Robin L. Hume, MS, Alison L. Hannah, MD, Bijan Nejadnik, MD, Robert J. Soiffer, MD

Blood (2015) 126 (23): 4311.

https://doi.org/10.1182/blood.V126.23.4311.4311

Published: 2015

Journal Articles

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial

Blood (2015) 126 (23): 737.

https://doi.org/10.1182/blood.V126.23.737.737

Published: 2015

Journal Articles

Pooled Treatment Analysis of Pediatric Patients with Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Multi-Organ Dysfunction Following Hematopoietic Stem Cell Transplant

Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Kamalika Banerjee, MS, Alison L. Hannah, MD, Robin L. Hume, MS, Bijan Nejadnik, MD, Paul Richardson, MD

Blood (2015) 126 (23): 4330.

https://doi.org/10.1182/blood.V126.23.4330.4330

Published: 2015

Journal Articles

Defibrotide for the Treatment of Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with/without Multi-Organ Dysfunction Following Chemotherapy: Results from an Ongoing Expanded Access Program

Nancy A. Kernan, MD, Paul G. Richardson, MD, Angela R. Smith, MD, Brandon M. Triplett, MD, Stephan A. Grupp, MD PhD, Joseph H. Antin, MD, Leslie E. Lehmann, MD, Wei Liang, PhD, Robin L. Hume, MS, Alison L. Hannah, MD, Bijan Nejadnik, MD, Robert J. Soiffer, MD

Blood (2015) 126 (23): 3121.

https://doi.org/10.1182/blood.V126.23.3121.3121

Published: 2015

Journal Articles

Updated Results from a Large, Ongoing, Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease

Paul G. Richardson, Angela R. Smith, MD MS, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Stephan A. Grupp, MD PhD, Sally Arai, MD, Joseph H. Antin, MD, Leslie E. Lehmann, MD, Valeria Bandiera, Robin L. Hume, MS, Alison L. Hannah, MD, Bijan Nejadnik, MD, Robert J. Soiffer, MD, Defibrotide Study Group

Blood (2014) 124 (21): 2470.

https://doi.org/10.1182/blood.V124.21.2470.2470

Published: 2014

Journal Articles

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients

Selim Corbacioglu, MD, Enric Carreras, MD PhD, Mohamad Mohty, MD PhD, Antonio Pagliuca, MD FRCP, FRCPath, Maria Ballabio, MD, Robin L. Hume, MS, Valeria Bandiera, Giorgia Finetto, Paul G. Richardson

Blood (2014) 124 (21): 1138.

https://doi.org/10.1182/blood.V124.21.1138.1138

Published: 2014

NARROW

Final Analysis of Day +100 Survival By Prior Hematopoietic Stem Cell Transplant Type from an Expanded Access Study of Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome

Adults Receiving Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program

Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Post-Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Neuroblastoma: Final Data from the Defibrotide Expanded-Access Program

Pooled Analysis of Day +100 Survival for Defibrotide-Treated Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) and Ventilator or Dialysis Dependence Following Hematopoietic Stem Cell Transplantation (HSCT)

Efficacy and Safety of Defibrotide in Pediatric Patients with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Stem Cell Transplantation (HSCT): Final Results from the Expanded-Access Program

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Early Initiation of Defibrotide in Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation Improves Day +100 Survival

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial

Pooled Treatment Analysis of Pediatric Patients with Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Multi-Organ Dysfunction Following Hematopoietic Stem Cell Transplant

Defibrotide for the Treatment of Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with/without Multi-Organ Dysfunction Following Chemotherapy: Results from an Ongoing Expanded Access Program

Updated Results from a Large, Ongoing, Treatment IND Study Using Defibrotide for Patients with Hepatic Veno-Occlusive Disease

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: An Update from the International Compassionate Use Program in 710 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only